NRX Pharmaceuticals, Inc. Payments to Fund Long-term Loans to Related Parties
NRX Pharmaceuticals, Inc. (NRXP) had Payments to Fund Long-term Loans to Related Parties of $154.19 thousand as of 2019-07-01, per its 10-Q/A filed 2022-08-12.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:PaymentsToFundLongtermLoansToRelatedParties · last filed 2022-08-12
- 2019-07-01: Payments to Fund Long-term Loans to Related Parties $154.19K.
| Period end | Payments to Fund Long-term Loans to Related Parties |
|---|---|
| 2019-07-01 | $154.19K 10-Q/A · filed 2022-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |